Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Almirall EPS Diluted (Quarterly) : 0.0821 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0821 |
| March 31, 2016 | 0.1386 |
| December 31, 2015 | 0.3558 |
| September 30, 2015 | 0.0862 |
| June 30, 2015 | 0.0966 |
| March 31, 2015 | 0.2679 |
| December 31, 2014 | 2.798 |
| September 30, 2014 | 0.1768 |
| June 30, 2014 | 0.0664 |
| March 31, 2014 | 0.0794 |
| December 31, 2013 | -0.4228 |
| September 30, 2013 | 0.0258 |
| June 30, 2013 | 0.0505 |
| March 31, 2013 | 0.0764 |
| December 31, 2012 | -0.1136 |
| September 30, 2012 | 0.4628 |
| June 30, 2012 | 0.0617 |
| March 31, 2012 | 0.1411 |
| December 31, 2011 | -0.0391 |
| September 30, 2011 | 0.1638 |
| June 30, 2011 | 0.324 |
| Date | Value |
|---|---|
| March 31, 2011 | 0.242 |
| December 31, 2010 | -0.013 |
| September 30, 2010 | 0.2666 |
| June 30, 2010 | 0.2681 |
| March 31, 2010 | 0.4104 |
| December 31, 2009 | 0.0853 |
| September 30, 2009 | 0.3198 |
| June 30, 2009 | 0.3205 |
| March 31, 2009 | 0.4751 |
| December 31, 2008 | 0.0253 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 0.2168 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.90M |
| Revenue (Quarterly) | 340.45M |
| Total Expenses (Quarterly) | 322.55M |
| Enterprise Value | 3.086B |
| Earnings Yield | 1.67% |
| Operating Earnings Yield | 2.43% |
| Normalized Earnings Yield | 1.365 |